The FDA says kids 10 and up with type 2 diabetes can use Awiqli® with a weekly shot.

NVO · Novo Nordisk

The AI's read

Fewer injections may make treatment easier for young patients and their caregivers. This gives Novo Nordisk a new treatment option for a defined group of patients. The approval covers children 10 years and older with type 2 diabetes, and Awiqli is used alongside diet and exercise. The report gives no sales or patient estimates, so the size of the business benefit is unknown.